The exaggerated systolic hypertensive response to exercise associates cardiovascular events: a systematic review and meta-analysis.
The pathophysiology of exaggerated systolic hypertensive response to exercise (SHRE) is not fully understood and its role in predicting cardiovascular (CV) events is contradictory. The aim of this review with meta-analysis was to analyze the association of SHRE with CV clinical outcomes in healthy normotensive subjects. Patients and methods: We searched Pubmed-MEDLINE, Cochrane Library, Refworks and Google Scholar aiming to find clinical studies which reported data on CV event rate and outcomes (coronary artery events, CV mortality and composite outcomes), for patients who underwent exercise testing and had SHRE. Sensitivity and speciﬁcity (with 95% CI) analysis for assessing the diagnostic accuracy of SHRE cut-off associated with CV events was estimated using hierarchical summary receiver operating characteristic analysis. Eight studies with 47,188 participants were included with a median follow-up duration of 19.3 years. Higher SHRE was found in patients with composite events - CV mortality and coronary artery disease (HR = 1.363 [1.135-1.604]; p<0.001), in those who developed coronary artery events (HR = 1.532 [1.240-1.893]; p<0.001) and CV mortality (HR = 1.286 [1.075-1.539]; p=0.006) compared to normal response individuals. An exercise systolic blood pressure of 196 mmHg predicted CV events with sensitivity of 62% (54-69%) and specificity of 75% (60-86%) with positive likelihood ratio (LR+) <3 and strong correlation (r=-0.71). This meta-analysis supports the clinical relevance of exaggerated SHRE as an associate of composite and individual CV clinical outcome. These findings should be taken as a thought-provoking evidence for identifying better stratification of such patients and consequently for optimum management of this, high risk, group.